Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments

Details for Australian Patent Application No. 2002331361 (hide)

Owner Bidachem S.P.A.

Inventors Ezhaya, Antoine; Dubini, Enrica; Bombarda, Carlo; Schneider, Heinrich

Agent Davies Collison Cave

Pub. Number AU-B-2002331361

PCT Number PCT/EP02/08466

PCT Pub. Number WO2003/014079

Priority 01118593.1 02.08.01 EP; 01130180.1 19.12.01 EP

Filing date 30 July 2002

Wipo publication date 24 February 2003

Acceptance publication date 5 June 2008

International Classifications

C07D 235/26 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 233/26 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

6 February 2003 Complete Application Filed

  Priority application(s): 01118593.1 02.08.01 EP; 01130180.1 19.12.01 EP

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002331361

14 December 2006 Amendment Made

  The nature of the amendment is: Add co-inventor Schneider, Heinrich

5 June 2008 Application Accepted

  Published as AU-B-2002331361

2 October 2008 Standard Patent Sealed

30 August 2012 Assignment Registered

  Bidachem S.P.A. The patent has been assigned to Sprout Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002331362-NEW ALKYNYLATED QUINAZOLIN COMPOUNDS AS MMP-13 INHIBITORS

2002331360-Use of LHRH-antagonists for the improvement of T-cell mediated immunity